Your search returned 16 results.

Results
	1.	The skinny on obesity and plasma cell myeloma: a review of the literature. [electronic resource] by Carson, K R Bates, M L Tomasson, M H Producer: 20150330 In: Bone marrow transplantation vol. 49 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways. [electronic resource] by Carroll, M Tomasson, M H Barker, G F Golub, T R Gilliland, D G Producer: 19970115 In: Proceedings of the National Academy of Sciences of the United States of America vol. 93 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	The TEL gene and human leukemia. [electronic resource] by Golub, T R McLean, T Stegmaier, K Carroll, M Tomasson, M Gilliland, D G Producer: 19960927 In: Biochimica et biophysica acta vol. 1288 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL. [electronic resource] by Li, S Gillessen, S Tomasson, M H Dranoff, G Gilliland, D G Van Etten, R A Producer: 20010419 In: Blood vol. 97 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Comparative effectiveness on survival of zoledronic acid versus pamidronate in multiple myeloma. [electronic resource] by Sanfilippo, K M Gage, B Luo, S Weilbaecher, K Tomasson, M Vij, R Colditz, G Carson, K Producer: 20160322 In: Leukemia & lymphoma vol. 56 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	TEL/PDGFbetaR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitor. [electronic resource] by Tomasson, M H Williams, I R Hasserjian, R Udomsakdi, C McGrath, S M Schwaller, J Druker, B Gilliland, D G Producer: 19990318 In: Blood vol. 93 Availability: No items available. Save to lists Add to cart (remove)
	7.	The TEL/PDGFbetaR fusion in chronic myelomonocytic leukemia signals through STAT5-dependent and STAT5-independent pathways. [electronic resource] by Sternberg, D W Tomasson, M H Carroll, M Curley, D P Barker, G Caprio, M Wilbanks, A Kazlauskas, A Gilliland, D G Producer: 20011220 In: Blood vol. 98 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factor or interleukin-3. [electronic resource] by Tomasson, M H Williams, I R Li, S Kutok, J Cain, D Gillessen, S Dranoff, G Van Etten, R A Gilliland, D G Producer: 20010419 In: Blood vol. 97 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Bortezomib administered pre-auto-SCT and as maintenance therapy post transplant for multiple myeloma: a single institution phase II study. [electronic resource] by Uy, G L Goyal, S D Fisher, N M Oza, A Y Tomasson, M H Stockerl-Goldstein, K DiPersio, J F Vij, R Producer: 20090819 In: Bone marrow transplantation vol. 43 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Fatal myeloproliferation, induced in mice by TEL/PDGFbetaR expression, depends on PDGFbetaR tyrosines 579/581. [electronic resource] by Tomasson, M H Sternberg, D W Williams, I R Carroll, M Cain, D Aster, J C Ilaria, R L Van Etten, R A Gilliland, D G Producer: 20000309 In: The Journal of clinical investigation vol. 105 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF alone. [electronic resource] by Devine, S M Brown, R A Mathews, V Trinkaus, K Khoury, H Adkins, D Vij, R Sempek, D Graubert, T Tomasson, M Goodnough, L T DiPersio, J F Producer: 20051202 In: Bone marrow transplantation vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Intrinsic human immunodeficiency virus type 1 resistance of hematopoietic stem cells despite coreceptor expression. [electronic resource] by Shen, H Cheng, T Preffer, F I Dombkowski, D Tomasson, M H Golan, D E Yang, O Hofmann, W Sodroski, J G Luster, A D Scadden, D T Producer: 19990128 In: Journal of virology vol. 73 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes. [electronic resource] by Schwaller, J Frantsve, J Aster, J Williams, I R Tomasson, M H Ross, T S Peeters, P Van Rompaey, L Van Etten, R A Ilaria, R Marynen, P Gilliland, D G Producer: 19981030 In: The EMBO journal vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma. [electronic resource] by Hao, M Franqui-Machin, R Xu, H Shaughnessy, J Barlogie, B Roodman, D Quelle, D E Janz, S Tomasson, M H Sanderson, R D Qiu, L Frech, I Tricot, G Zhan, F Producer: 20180612 In: Leukemia vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Supraventricular tachyarrhythmias after hematopoietic stem cell transplantation: incidence, risk factors and outcomes. [electronic resource] by Hidalgo, J D Krone, R Rich, M W Blum, K Adkins, D Fan, M-Y Brown, R Devine, S Graubert, T Blum, W Tomasson, M Goodnough, L T Vij, R DiPersio, J Khoury, H Producer: 20050216 In: Bone marrow transplantation vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects. [electronic resource] by Hurchla, M A Garcia-Gomez, A Hornick, M C Ocio, E M Li, A Blanco, J F Collins, L Kirk, C J Piwnica-Worms, D Vij, R Tomasson, M H Pandiella, A San Miguel, J F Garayoa, M Weilbaecher, K N Producer: 20130404 In: Leukemia vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)